BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18684217)

  • 21. Lipid levels after acute coronary syndromes.
    Pitt B; Loscalzo J; Ycas J; Raichlen JS
    J Am Coll Cardiol; 2008 Apr; 51(15):1440-5. PubMed ID: 18402897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid response to lipids profile and leukocyte gene expression after rosuvastatin administration in Chinese healthy volunteers.
    Hua CX; Li YS; Liu YQ; Liu H; Li N; Wu Y; Xu L; Huang YL
    Chin Med J (Engl); 2008 Jul; 121(13):1215-9. PubMed ID: 18710642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rosuvastatin: pharmacologic features].
    Bernini F; Catapano AL
    Ital Heart J; 2003 Dec; 4 Suppl 7():22S-32S. PubMed ID: 14983744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.
    Burmeister JE; Miltersteiner DR; Campos BM
    J Nephrol; 2009; 22(1):83-9. PubMed ID: 19229822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes.
    Tarhzaoui K; Valensi P; Boulakia FC; Lestrade R; Albertini JP; Behar A
    Diabetes Res Clin Pract; 2008 Jun; 80(3):335-43. PubMed ID: 18406000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR; Tandon M; Sharma PL
    Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoglycemic and hypolipidemic effects of fresh leaf aqueous extract of Cymbopogon citratus Stapf. in rats.
    Adeneye AA; Agbaje EO
    J Ethnopharmacol; 2007 Jul; 112(3):440-4. PubMed ID: 17513076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneously administrated genistein and daidzein decrease serum cholesterol and increase triglyceride levels in male middle-aged rats.
    Sosić-Jurjević B; Filipović B; Ajdzanović V; Brkić D; Ristić N; Stojanoski MM; Nestorović N; Trifunović S; Sekulić M
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1222-7. PubMed ID: 17895530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
    Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
    Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of smoking on mean platelet volume and lipid profile in young male subjects].
    Arslan E; Yakar T; Yavaşoğlu I
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):422-5. PubMed ID: 19103537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.
    Kim S; Kim CH; Vaziri ND
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E813-7. PubMed ID: 15585592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).
    Wiviott SD; Mohanavelu S; Raichlen JS; Cain VA; Nissen SE; Libby P
    Am J Cardiol; 2009 Jul; 104(1):29-35. PubMed ID: 19576317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol levels in patients with multiple myeloma.
    Yavasoglu I; Tombuloglu M; Kadikoylu G; Donmez A; Cagirgan S; Bolaman Z
    Ann Hematol; 2008 Mar; 87(3):223-8. PubMed ID: 17874102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug of the month. Rosuvastatin (Crestor)].
    Scheen AJ
    Rev Med Liege; 2004 Jan; 59(1):56-9. PubMed ID: 15035545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypolipidemic activity of Anethum graveolens in rats.
    Hajhashemi V; Abbasi N
    Phytother Res; 2008 Mar; 22(3):372-5. PubMed ID: 18058989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy.
    Sharma H; Pathan RA; Kumar V; Javed S; Bhandari U
    Int J Cardiol; 2011 Jul; 150(2):193-200. PubMed ID: 20452068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin attenuates diet-induced hypercholesterolemia in rats.
    Arafa HM
    Med Sci Monit; 2005 Jul; 11(7):BR228-234. PubMed ID: 15990684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihyperlipidemic effect of the methanolic extract from Lagenaria siceraria Stand. fruit in hyperlipidemic rats.
    Ghule BV; Ghante MH; Saoji AN; Yeole PG
    J Ethnopharmacol; 2009 Jul; 124(2):333-7. PubMed ID: 19397976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.